Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | AMGN | GILD | CELG | ILMN |
| Company | Apellis Pharmaceuticals Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 36.24 | 337.03 | 84.39 | 108.01 | 134.92 |
| High | 37.84 | 338.70 | 84.65 | 108.59 | 136.19 |
| Low | 36.10 | 334.61 | 83.57 | 107.27 | 133.88 |
| Last | 36.83 | 337.16 | 84.56 | 108.24 | 135.32 |
| Change | +1.20 | +4.24 | +0.67 | +0.11 | +4.35 |
| % Change | +3.37% | +1.27% | +0.80% | +0.10% | +3.32% |
| Volume | 779,404 | 594,006 | 3,346,491 | 191,230,496 | 464,582 |
| 20-Day Average Volume | 1,133,755 | 1,707,250 | 6,413,796 | 16,188,930 | 1,315,668 |
| Previous Close | 35.63 | 332.92 | 83.89 | 108.13 | 130.97 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 38.39 | 329.62 | 80.10 | 108.17 | 129.23 |
| 20-Day Raw Stochastic | 27.13% | 88.15% | 94.81% | 63.25% | 93.25% |
| 20-Day Relative Strength | 46.93% | 58.17% | 72.81% | 64.69% | 61.14% |
| Weighted Alpha | -27.83 | +27.45 | +19.20 | +46.30 | +9.23 |
| Today's Opinion | 88% Sell | 96% Buy | 88% Buy | 100% Buy | 72% Buy |
| Previous Opinion | 88% Sell | 88% Buy | 88% Buy | 100% Buy | 64% Buy |
| Last Month's Opinion | 64% Sell | 88% Buy | 56% Buy | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.60% since 09/12/24 | +1.99% since 09/12/24 | +1.49% since 09/12/24 | -1.97% since 11/13/19 | +6.99% since 09/12/24 |
| Low | 35.16 on 09/17/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 107.27 on 11/20/19 | 126.31 on 09/13/24 |
| High | 38.55 on 09/13/24 | 339.00 on 09/18/24 | 84.61 on 09/19/24 | 110.53 on 11/14/19 | 136.13 on 09/19/24 |
| 1-Month | |||||
| %Chg | -4.07% since 08/19/24 | +2.64% since 08/19/24 | +13.36% since 08/19/24 | +5.14% since 10/18/19 | -0.60% since 08/19/24 |
| Low | 35.16 on 09/17/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 102.40 on 10/21/19 | 120.51 on 09/12/24 |
| High | 41.94 on 09/09/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 137.18 on 08/20/24 |
| 3-Month | |||||
| %Chg | -7.66% since 06/18/24 | +10.01% since 06/18/24 | +33.64% since 06/18/24 | +13.63% since 08/20/19 | +24.96% since 06/18/24 |
| Low | 33.49 on 08/05/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 93.41 on 08/23/19 | 103.52 on 06/28/24 |
| High | 42.47 on 07/16/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 137.18 on 08/20/24 |
| 6-Month | |||||
| %Chg | -35.00% since 03/19/24 | +23.88% since 03/19/24 | +14.96% since 03/19/24 | +14.14% since 05/20/19 | +1.44% since 03/19/24 |
| Low | 33.49 on 08/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 100.08 on 05/30/24 |
| High | 59.91 on 04/01/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 144.19 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,324,271 | 178,589,936 | 104,514,608 | 77,035,920 | 20,863,522 |
| Shares Outstanding, K | 121,366 | 536,435 | 1,245,853 | 711,714 | 159,300 |
| Annual Sales | 396,590,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -528,630,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 199,690,000 | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 1,112,000,000 |
| Last Quarter Net Income | -37,660,000 | 746,000,000 | 1,614,000,000 | 1,691,000,000 | -1,988,000,000 |
| 60-Month Beta | 0.88 | 0.61 | 0.18 | 1.41 | 1.15 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.28 on 08/01/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | 0.36 on 08/06/24 |
| Latest Earnings Date | 11/06/24 | 10/29/24 | 11/05/24 | 10/31/19 | 08/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.89 | 17.67 | 10.99 | 141.53 |